Price
Financials
Standalone, Rs crore| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 40.37 | 38.64 | 51.96 | 520.86 | 246.90 | 11.30 | 13.04 | 14.45 | 25.30 | 28.17 | 22.04 | 16.58 |
| Expenses | 42.64 | 36.37 | 54.44 | 500.99 | 240.23 | 8.19 | 12.16 | 14.39 | 25.47 | 26.38 | 22.45 | 16.68 |
| Operating Profit | -2.27 | 2.27 | -2.48 | 19.87 | 6.67 | 3.11 | 0.88 | 0.06 | -0.17 | 1.79 | -0.41 | -0.10 |
| OPM % | -5.62% | 5.87% | -4.77% | 3.81% | 2.70% | 27.52% | 6.75% | 0.42% | -0.67% | 6.35% | -1.86% | -0.60% |
| Other Income | 2.09 | -1.63 | 0.58 | 0.90 | 5.05 | 12.37 | 1.94 | 0.09 | 0.19 | 0.07 | 0.53 | 0.15 |
| Interest | 0.62 | 0.08 | 0.34 | 12.62 | 11.69 | 0.29 | 0.24 | 0.02 | 0.03 | 0.15 | 0.01 | 0.01 |
| Depreciation | 2.39 | 2.40 | 2.39 | 2.36 | 0.18 | 0.20 | 0.15 | 0.00 | 0.00 | 0.02 | 0.05 | 0.04 |
| Profit before tax | -3.19 | -1.84 | -4.63 | 5.79 | -0.15 | 14.99 | 2.43 | 0.13 | -0.01 | 1.69 | 0.06 | 0.00 |
| Tax % | 3.13% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.96% | 500.00% | |
| Net Profit | -3.28 | -1.84 | -4.63 | 5.79 | -0.15 | 14.99 | 2.44 | 0.12 | -0.01 | 1.65 | -0.24 | 0.00 |
| EPS in Rs | ||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -29% | % | -13% | -25% | ||
| Compounded Profit Growth | % | % | % | 100% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | 33% | 32% | 0% |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 |
| Reserves | -119.11 | -105.61 | -110.24 | -104.45 | -104.61 | -89.62 | -92.92 | -12.34 | -12.35 | -10.70 | -10.94 | -10.94 |
| Borrowings | 131.12 | 113.05 | 110.29 | 297.19 | 95.70 | 95.73 | 99.47 | 10.96 | 10.47 | 10.61 | 10.55 | 10.55 |
| Other Liabilities | 14.60 | 13.39 | 58.22 | 34.47 | 19.82 | 15.61 | 14.22 | 20.13 | 20.31 | 23.32 | 26.27 | 18.84 |
| Total Liabilities | 39.11 | 33.33 | 70.77 | 239.71 | 23.41 | 34.22 | 33.27 | 31.25 | 30.93 | 35.73 | 38.38 | 30.95 |
| Fixed Assets | 18.84 | 16.50 | 14.13 | 1.58 | 1.61 | 1.36 | 1.64 | 0.00 | 0.00 | 0.13 | 0.14 | 0.11 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.12 | 0.24 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 20.27 | 16.83 | 56.64 | 238.01 | 21.56 | 32.62 | 31.63 | 31.25 | 30.93 | 35.60 | 38.24 | 30.84 |
| Total Assets | 39.11 | 33.33 | 70.77 | 239.71 | 23.41 | 34.22 | 33.27 | 31.25 | 30.93 | 35.73 | 38.38 | 30.95 |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 2.14 | 3.33 | -154.49 | 218.32 | -13.15 | 3.94 | -0.18 | 0.84 | -0.22 | -0.09 | -0.08 | |
| Cash from Investing Activity | -0.06 | -0.02 | 10.24 | -0.17 | 12.30 | -0.17 | 0.04 | 0.04 | -0.11 | -0.02 | 0.03 | |
| Cash from Financing Activity | -2.24 | -2.76 | 145.72 | 219.14 | -0.29 | -2.90 | 0.15 | -0.52 | 0.10 | -0.07 | 0.00 | |
| Net Cash Flow | -0.16 | 0.55 | 1.47 | 437.29 | -1.15 | 0.86 | 0.01 | 0.36 | -0.23 | -0.18 | -0.05 | |
| Free Cash Flow | 2.08 | 3.31 | -144.31 | 218.24 | -0.89 | 3.48 | -0.18 | 0.84 | -0.37 | -0.15 | -0.08 | |
| CFO/OP | 94% | -134% | -778% | 3,273% | -424% | 481% | -283% | -494% | 3% | -132% | 80% |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77.85 | 75.29 | 332.05 | 152.45 | 8.78 | 587.88 | 442.25 | 170.25 | 61.31 | 88.37 | 137.95 | 68.91 |
| Inventory Days | 65.71 | 52.10 | 20.03 | 4.24 | 3.11 | 161.92 | 49.57 | 34.24 | 30.02 | 46.45 | 71.98 | 3.41 |
| Days Payable | 130.03 | 120.08 | 68.13 | 15.08 | 5.46 | 458.31 | 192.76 | 319.74 | 171.61 | 373.78 | 565.28 | 282.67 |
| Cash Conversion Cycle | 13.53 | 7.31 | 283.95 | 141.61 | 6.43 | 291.49 | 299.06 | -115.25 | -80.27 | -238.96 | -355.35 | -210.35 |
| Working Capital Days | 43.49 | 25.88 | -19.88 | 141.95 | 5.57 | 624.05 | 424.62 | -15.41 | -11.97 | 12.05 | 14.24 | 25.32 |
| ROCE % | -9.76% | -7.92% | -26.41% | 16.91% | 11.05% | 137.12% | 16.94% | 0.37% | 15.89% | 0.65% | 0.08% |
Fundamentals
Market Cap₹ Cr.
Current Price₹
Book Value₹
ROCE0.08 %
ROE0.00 %
Dividend Yield%
Face Value₹ 10.0
Compounded Sales Growth (TTM)-25%
Compounded Profit Growth (TTM)100%
Standalone figures.
Profitability
Operating margin (excl. other income)-0.60%
Operating margin (incl. other income)0.30%
ROE, 3-year average77.47%
ROCE, 3-year average8.28%
ROA, 3-year average2.15%
ROE, 5-year average37.05%
ROCE, 5-year average4.43%
ROA, 5-year average1.16%
Other income / net worth9.62%
Growth
Sales growth (latest year)-24.77%
Sales CAGR, 3 years-13.14%
Sales CAGR, 5 years4.92%
Per share
EPS, 3-year averageRs 0.56
EPS, 5-year averageRs 0.30
Book value per shareRs 1.25
Sales per shareRs 13.26
Cash flow per shareRs -0.06
Free cash flow per shareRs -0.06
Efficiency
Asset turnover0.54x
Fixed asset turnover150.73x
Inventory turnover121.89x
Inventory days3 days
Debtor days69 days
Debtors turnover5.30x
Creditor days283 days
Cash conversion cycle-210 days
Working capital days25 days
Leverage
Total debtRs 11 Cr
Cash and bankRs 0 Cr
Net debtRs 11 Cr
Debt to equity6.76x
Owners' fund to total sources5.04%
Debt to assets34.09%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Cash from Investing Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs -0 Cr
FCFE (approx.: FCF + change in debt)Rs -0 Cr
Cash from ops / profit, 5 years0.18x
Statement figures
Net sales (TTM)Rs 17 Cr
Net sales (latest year)Rs 17 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Other income (TTM)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 11 Cr
Total expenditure (latest year)Rs 17 Cr
Total income (latest year)Rs 17 Cr
Share capitalRs 12 Cr
ReservesRs -11 Cr
Shareholders' fundsRs 2 Cr
Total assetsRs 31 Cr
Net blockRs 0 Cr
ReceivablesRs 3 Cr
InventoryRs 0 Cr
Other liabilitiesRs 19 Cr
Shares outstanding (crore)1.25
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 3 of 8| explain | Weak cash conversion Cash from operations was 38% of net profit over the last 3 years |
| explain | Receivables outrunning sales Receivables grew 22% vs sales -22% in 2021 |
| look | Profit leans on other income Other income was 883% of pre-tax profit in 2021 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
CompareNo listed peers in this industry.
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2008-09-25 | Annual General Meeting | |
| 2007-11-08 | Agm | |
| 2006-09-26 | Agm |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Cepham Milk Specialities Ltd?
Cepham Milk Specialities Ltd (CEPHAMILK) has a market capitalisation of Rs Cr. at the close.